TCRT vs TELO

Alaunos Therapeutics, Inc. vs Telomir Pharmaceuticals, Inc. — Valuation Comparison 2026

TCRT

Biotechnology
Alaunos Therapeutics, Inc.
Quality
4.4
out of 10
Value Trap
33
LOW
Price
$3.06
Last close
Models
8/13
Active
VS

TELO

Biotechnology
Telomir Pharmaceuticals, Inc.
Quality
4.2
out of 10
Value Trap
Price
$1.28
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType TCRT Fair ValueTCRT Upside TELO Fair ValueTELO Upside
Bayesian DCF Intrinsic $0.90 -70.7% $0.38 -70.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.09 -96.4% $0.02 -98.9%
Dynamic NAV Asset-Based $0.11 -91.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TCRT vs TELO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TCRT vs TELO — Which Stock Is More Undervalued?

TCRT scores higher with a 4.4/10 quality rating vs TELO's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Alaunos Therapeutics, Inc. (TCRT) and Telomir Pharmaceuticals, Inc. (TELO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TCRT currently trades at $3.06 with a QOC of 4.4/10, while TELO trades at $1.28 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).